攝護腺癌早期診斷指引：摘譯2014年美國泌尿科醫學會評論

Early Detection of Prostate Cancer: Selective Translation of 2014 American Urological Association Update Series Review

黃柏仁(Po-Jen Huang) ； 邱逸淳(Yi-Chun Chiu)

《北市醫學雜誌》 12卷3期 (2015/09) Pp. 1-8

https://doi.org/10.6200/TCMJ.2015.12.3.01

摘要

攝護腺癌是男性常見的惡性腫瘤，而攝護腺特異性抗原指數Prostate specific antigen (PSA)在無症狀男性作為攝護腺癌篩有可能因過度診斷、過度治療而為病人帶來生理及心理的傷害，因此美國泌尿科醫學會於根據大型研究結果，依不同年齡層（小於40歲、40~54歲、55~69歲、70歲以上）制定出攝護腺癌早期診斷指引。本文已獲得美國泌尿科醫學會同意翻譯，作者簡介美國泌尿科醫學會對此指引的內容及討論，希望能提昇醫護人員對攝護腺癌篩檢的重視，提高攝護腺癌的診斷率，同時避免因篩檢所帶來的傷害。

關鍵字

攝護腺癌 ； 攝護腺癌篩檢 ； 攝護腺特異性抗原 ； 早期癌症偵測

並列摘要

Prostate cancer is a common malignancy in men. Prostate-specific antigen (PSA) screening in asymptomatic men may bring physical and psychological harm to the patients because of overdiagnosis and overtreatment. Therefore, based on the findings on large studies, the American Urological Association formed clinical guidelines for the early detection of prostate cancer according to age groups (age＜40; 40 to 54; 55 to 69; ≥70). Through introduction and discussion of the contents, we wish to raise awareness of the importance of prostate cancer screening among medical staff, improve the diagnosis of prostate cancer, and avoid damage brought by the screening.

並列關鍵字

prostate cancer ； prostate cancer screening ； prostate specific antigen (PSA) ； early detection of cancer